Description
Semax is a synthetic peptide analog explored primarily in neuroprotection and gene-expression modulation studies, with much literature concentrated in preclinical or regional contexts.
What it is
Semax is a synthetic ACTH(4-7)-PGP analog studied mainly in CNS preclinical work, including stroke-model and neuroinflammatory signaling research.
Mechanism snapshot
- Investigated for neurotrophin- and transcription-related pathway modulation.
- Studied for suppression of pro-inflammatory signaling in ischemic models.
- Evaluated through transcriptomic and proteomic response analysis.
Research programs
- Ischemia-reperfusion and post-stroke model systems.
- CNS immune-gene expression studies.
- Comparative ACTH-like peptide signaling projects.
Limitations
- Rodent-to-human translational gaps remain significant.
- Clinical generalizability is constrained by available datasets.
- More rigorous large-scale human studies are needed.
Selected references
- Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion - PubMed 2021
- Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats - PubMed 2017
- ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke - PubMed 2024
Ordering
Add this item to your cart, submit your shipping details at checkout, and wait for your order confirmation. Interac e-Transfer instructions are sent after the order request is received.



